METHYL SALICYLATE AND MENTHOL

METHYL SALICYLATE AND MENTHOL was reported 81 times

METHYL SALICYLATE AND MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
1 SERUM AMYLOID A PROTEIN INCREASED 1 0.0065
2 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
3 EPIDURAL INJECTION 1 0.0051
4 EXPOSURE VIA INHALATION 1 0.0046
5 CATHETER SITE RELATED REACTION 1 0.0013
6 PERIORBITAL PAIN 1 0.0012
7 MEDICATION OVERUSE HEADACHE 1 0.0012
8 BURNS SECOND DEGREE 2 0.0011
9 BURNS THIRD DEGREE 1 0.0009
10 CARDIAC HYPERTROPHY 1 0.0009
11 CATHETER SITE DISCHARGE 1 0.0009
12 OVARIAN CYST RUPTURED 1 0.0008
13 TONGUE DRY 1 0.0007
14 HALLUCINATIONS, MIXED 3 0.0007
15 CONNECTIVE TISSUE DISORDER 1 0.0007
16 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
17 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
18 NIPPLE PAIN 1 0.0005
19 MENOPAUSE 1 0.0004
20 ANORGASMIA 1 0.0004
21 JOINT LOCK 1 0.0004
22 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
23 SINUS HEADACHE 2 0.0003
24 ATYPICAL PNEUMONIA 1 0.0003
25 PLANTAR FASCIITIS 1 0.0003
26 BOWEL MOVEMENT IRREGULARITY 2 0.0003
27 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
28 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
29 OESOPHAGEAL CANDIDIASIS 1 0.0003
30 ENURESIS 1 0.0002
31 SLEEP TERROR 1 0.0002
32 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
33 HEPATIC PAIN 1 0.0002
34 LIGAMENT RUPTURE 1 0.0002
35 HAEMOGLOBIN INCREASED 1 0.0002
36 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
37 SKIN TIGHTNESS 1 0.0002
38 VULVOVAGINAL PAIN 1 0.0002
39 INCREASED UPPER AIRWAY SECRETION 1 0.0002
40 SENSITIVITY TO WEATHER CHANGE 1 0.0002
41 PHARYNGOLARYNGEAL PAIN 1 0.0002
42 PRE-EXISTING CONDITION IMPROVED 1 0.0002
43 PROCTALGIA 1 0.0002
44 HERPES SIMPLEX 1 0.0002
45 TENDON DISORDER 1 0.0002
46 SKIN MASS 1 0.0001
47 MENINGITIS 1 0.0001
48 ONYCHOCLASIS 1 0.0001
49 APPLICATION SITE REACTION 1 0.0001
50 SEASONAL ALLERGY 2 0.0001
51 CEREBRAL DISORDER 1 0.0001
52 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
53 CONCUSSION 1 0.0001
54 MULTIPLE ALLERGIES 1 0.0001
55 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
56 FRUSTRATION TOLERANCE DECREASED 1 0.0001
57 ESCHERICHIA INFECTION 1 0.0001
58 INADEQUATE ANALGESIA 1 0.0001
59 BLOOD CALCIUM INCREASED 1 0.0001
60 INCREASED TENDENCY TO BRUISE 1 0.0001
61 OVARIAN CANCER 1 0.0001
62 FLANK PAIN 1 0.0001
63 SPUTUM DISCOLOURED 1 0.0001
64 THERAPY CHANGE 1 0.0001
65 DISORIENTATION 4 0.0001
66 OVARIAN CYST 1 0.0001
67 EUPHORIC MOOD 1 0.0001
68 PRODUCT ODOUR ABNORMAL 1 0.0001
69 BODY HEIGHT DECREASED 1 0.0001
70 IRRITABLE BOWEL SYNDROME 2 0.0001
71 DECREASED ACTIVITY 1 0.0001
72 ORAL PAIN 2 0.0001
73 APPLICATION SITE PRURITUS 2 0.0001
74 MICTURITION URGENCY 1 0.0001
75 SPLENOMEGALY 1 0.0001
76 SPINAL PAIN 1 0.0001
77 BURSITIS 1 0.0001
78 INCORRECT PRODUCT STORAGE 1 0.0001
79 PRODUCT TASTE ABNORMAL 1 0.0001
80 APPLICATION SITE RASH 1 0.0001
81 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
82 BLINDNESS UNILATERAL 1 0.0001
83 PAIN IN JAW 2 0.0001
84 MUSCULOSKELETAL CHEST PAIN 1 0.0001
85 TENDONITIS 1 0.0001
86 MUSCLE TIGHTNESS 1 0.0001
87 BLOOD POTASSIUM INCREASED 1 0.0001
88 URINARY RETENTION 2 0.0001
89 MUSCULOSKELETAL DISCOMFORT 1 0.0001
90 THIRST 1 0.0001
91 TOOTHACHE 1 0.0001
92 BLISTER 3 0.0001
93 DYSPNOEA EXERTIONAL 2 0.0001
94 CHOLESTASIS 1 0.0001
95 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
96 SINUS DISORDER 1 0.0001
97 FULL BLOOD COUNT DECREASED 1 0.0000
98 PRODUCT PHYSICAL ISSUE 1 0.0000
99 RIB FRACTURE 1 0.0000
100 PULMONARY HYPERTENSION 1 0.0000
101 FAECES DISCOLOURED 1 0.0000
102 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
103 APPLICATION SITE PAIN 1 0.0000
104 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
105 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
106 SKIN IRRITATION 2 0.0000
107 MENTAL IMPAIRMENT 1 0.0000
108 NEURALGIA 1 0.0000
109 AGEUSIA 1 0.0000
110 ANAPHYLACTIC SHOCK 1 0.0000
111 APPLICATION SITE ERYTHEMA 1 0.0000
112 FREQUENT BOWEL MOVEMENTS 1 0.0000
113 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
114 BACK PAIN 8 0.0000
115 PSYCHOTIC DISORDER 1 0.0000
116 IRRITABILITY 2 0.0000
117 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
118 DISCOMFORT 2 0.0000
119 NEUROPATHY PERIPHERAL 3 0.0000
120 CYSTITIS 1 0.0000
121 CHOLELITHIASIS 1 0.0000
122 TREMOR 5 0.0000
123 ANGER 1 0.0000
124 HAEMATURIA 1 0.0000
125 GASTRIC DISORDER 1 0.0000
126 RASH MACULAR 1 0.0000
127 BURNING SENSATION 2 0.0000
128 MOBILITY DECREASED 2 0.0000
129 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
130 CRYING 1 0.0000
131 C-REACTIVE PROTEIN INCREASED 1 0.0000
132 BRONCHITIS 2 0.0000
133 RHEUMATOID ARTHRITIS 3 0.0000
134 PERIPHERAL SWELLING 4 0.0000
135 POLLAKIURIA 1 0.0000
136 ROAD TRAFFIC ACCIDENT 1 0.0000
137 URTICARIA 4 0.0000
138 OSTEOARTHRITIS 1 0.0000
139 HYPOACUSIS 1 0.0000
140 PSORIASIS 3 0.0000
141 MUSCULOSKELETAL STIFFNESS 2 0.0000
142 RENAL FAILURE 3 0.0000
143 THERAPY NON-RESPONDER 1 0.0000
144 NEPHROLITHIASIS 1 0.0000
145 SKIN DISCOLOURATION 1 0.0000
146 COGNITIVE DISORDER 1 0.0000
147 DYSPHAGIA 2 0.0000
148 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
149 CONTUSION 2 0.0000
150 LUNG DISORDER 1 0.0000
151 CHEST DISCOMFORT 2 0.0000
152 SINUSITIS 2 0.0000
153 THERAPY CESSATION 1 0.0000
154 SPEECH DISORDER 1 0.0000
155 DRUG EFFECT DECREASED 1 0.0000
156 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
157 ARTHROPATHY 1 0.0000
158 MEDICATION ERROR 1 0.0000
159 NECK PAIN 1 0.0000
160 PANCYTOPENIA 1 0.0000
161 OXYGEN SATURATION DECREASED 1 0.0000
162 FLATULENCE 1 0.0000
163 SEIZURE 2 0.0000
164 NASAL CONGESTION 1 0.0000
165 DISEASE PROGRESSION 2 0.0000
166 STOMATITIS 1 0.0000
167 VERTIGO 1 0.0000
168 VISUAL IMPAIRMENT 2 0.0000
169 HYPERHIDROSIS 2 0.0000
170 AMNESIA 1 0.0000
171 PRODUCT DOSE OMISSION 1 0.0000
172 ERYTHEMA 3 0.0000
173 MEMORY IMPAIRMENT 2 0.0000
174 INJURY 1 0.0000
175 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
176 PAIN IN EXTREMITY 4 0.0000
177 WEIGHT INCREASED 3 0.0000
178 UNEVALUABLE EVENT 1 0.0000
179 PAIN 8 0.0000
180 ARTHRITIS 1 0.0000
181 CARDIAC FAILURE CONGESTIVE 1 0.0000
182 DRY MOUTH 1 0.0000
183 NAUSEA 9 0.0000
184 GASTROINTESTINAL DISORDER 1 0.0000
185 MUSCLE SPASMS 2 0.0000
186 ASTHENIA 4 0.0000
187 MIGRAINE 1 0.0000
188 PRURITUS 4 0.0000
189 ATRIAL FIBRILLATION 1 0.0000
190 PRODUCT DOSE OMISSION ISSUE 3 0.0000
191 DYSPEPSIA 1 0.0000
192 SYNCOPE 1 0.0000
193 HYPOTENSION 2 0.0000
194 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
195 FLUSHING 1 0.0000
196 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
197 ARTHRALGIA 4 0.0000
198 FALL 3 0.0000
199 ASTHMA 1 0.0000
200 DYSPNOEA 5 0.0000
201 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
202 ABDOMINAL PAIN 2 0.0000
203 CHILLS 1 0.0000
204 VOMITING 4 0.0000
205 JOINT SWELLING 1 0.0000
206 OEDEMA PERIPHERAL 1 0.0000
207 DRUG INEFFECTIVE 10 0.0000
208 WEIGHT DECREASED 2 0.0000
209 COUGH 2 0.0000
210 HYPOAESTHESIA 1 0.0000
211 BLOOD PRESSURE INCREASED 1 0.0000
212 FATIGUE 5 0.0000
213 PNEUMONIA 2 0.0000
214 DRUG DOSE OMISSION 1 0.0000
215 DIZZINESS 3 0.0000
216 ABDOMINAL DISCOMFORT 1 0.0000
217 MYALGIA 1 0.0000
218 URINARY TRACT INFECTION 1 0.0000
219 PYREXIA 2 0.0000
220 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
221 NASOPHARYNGITIS 1 0.0000
222 CHEST PAIN 1 0.0000
223 HYPERSENSITIVITY 1 0.0000
224 PRODUCT USE ISSUE 1 0.0000
225 GAIT DISTURBANCE 1 0.0000
226 ABDOMINAL PAIN UPPER 1 0.0000
227 HEADACHE 3 0.0000
228 DIARRHOEA 3 0.0000
229 RASH 2 0.0000
230 CONSTIPATION 1 0.0000
231 DEPRESSION 1 0.0000
232 INCORRECT DOSE ADMINISTERED 1 0.0000
233 DECREASED APPETITE 1 0.0000
234 FEELING ABNORMAL 1 0.0000
235 INSOMNIA 1 0.0000
236 ANXIETY 1 0.0000
237 CONDITION AGGRAVATED 1 0.0000
238 INJECTION SITE PAIN 1 0.0000
239 MALAISE 1 0.0000